RT Generic
T1 Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy.
A1 Otero, Remedios
A1 Bertoletti, Laurent
A1 Muriel, Alfonso
A1 Siniscalchi, Carmine
A1 Jimenez, Carmen
A1 Luis Lobo, Jose
A1 Kigitovica, Dana
A1 Quintavalla, Roberto
A1 Rocci, Anna
A1 Jara-Palomares, Luis
A1 Monreal, Manuel
K1 Decision Support Techniques
K1 Europe
K1 Hypertension, Pulmonary
K1 Pulmonary Embolism
AB Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and serious complication after pulmonary embolism (PE). Its incidence in the general population is around 3–30 cases per million. The incidence of CTEPH after acute PE ranges between 0.1 and 8.8% [1–5]. In a meta-analysis including 4047 PE patients, the incidence of CTEPH was 2.8% (95% CI 1.5–4.1) in “PE survivors” without major comorbidities [6]. In studies not using objective diagnostic criteria to diagnose CTEPH, the pooled incidence was 6.3% (95% CI 4.1–8.4)
PB European Respiratory Society
SN 0903-1936
YR 2018
FD 2018-04-19
LK http://hdl.handle.net/10668/12201
UL http://hdl.handle.net/10668/12201
LA en
NO Otero R, Bertoletti L, Muriel A, Siniscalchi C, Jimenez C, Luis Lobo J, et al. Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy. Eur Respir J. 2018 Apr 19;51(4):1702576.
DS RISalud
RD Jul 31, 2025